Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer’s Disease
Journal of Alzheimer's Disease · 16.01.2024 · 97 (2) · 841-853
DOI: 10.3233/jad-220857 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 16.01.2024. Verfasst von Lyna Mariam El Haffaf und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, CIUSSS du Centre-Sud-de-l'Ile-de-Montreal, Montréal, QC, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Background
Hyperactive neuropsychiatric symptoms (NPS) (i.e., agitation, disinhibition, and irritability) are among the most challenging symptoms to manage in Alzheimer’s disease (AD). However, their underlying brain correlates have been poorly studied.
Objective
We aimed to investigate the associations between the total score of hyperactive NPS and brain structures in participants with AD, mild cognitive impairment (MCI), and cognitively normal older adults (CN).
Methods
Neuropsychiatric and 3T MRI data from 216 AD, 564 MCI, and 660 CN participants were extracted from the Alzheimer’s Disease Neuroimaging Initiative database. To define NPS and brain structures’ associations, we fitted a general linear model (GLM) in two ways: 1) an overall GLM including all three groups (AD, MCI, CN) and 2) three pair-wise GLMs (AD versus MCI, MCI versus CN, AD versus CN). The cortical changes as a function of NPS total score were investigated using multiple regression analyses.
Results
Results from the overall GLM include associations between 1) agitation and the right parietal supramarginal surface area in the MCI-CN contrast, 2) disinhibition and the cortical thickness of the right frontal pars opercularis and temporal inferior in the AD-MCI contrast, and 3) irritability and the right frontal pars opercularis, frontal superior, and temporal superior volumes in the MCI-CN contrast.
Conclusions
Our study shows that each hyperactive NPS is associated with distinct brain regions in AD, MCI, and CN (groups with different levels of cognitive performance). This suggests that each NPS is associated with a unique signature of brain morphology, including variations in volume, thickness, or area.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, CIUSSS du Centre-Sud-de-l'Ile-de-Montreal, Montréal, QC, Canada.
- Département de Psychologie, Faculté des Arts et des Sciences, Université de Montréal, Montréal, QC, Canada.
- Département de Médecine, Faculté de Médecine, Université de Montréal, Montréal, QC, Canada.
Förderung
- NIA NIH HHS
Zitieren
APA
El Haffaf, L. M., Ronat, L., Cannizzaro, A., Hanganu, A., & Alzheimer’s Disease Neuroimaging Initiative (2024). Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer’s Disease. Journal of Alzheimer's Disease, 97(2), 841-853. https://doi.org/10.3233/jad-220857
Vancouver
El Haffaf LM, Ronat L, Cannizzaro A, Hanganu A, Alzheimer’s Disease Neuroimaging Initiative. Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer’s Disease. Journal of Alzheimer's Disease. 2024;97(2):841-853. doi:10.3233/jad-220857
BibTeX
@article{ElHaffaf2024,
author = {El Haffaf, Lyna Mariam and Ronat, Lucas and Cannizzaro, Adriana and Hanganu, Alexandru and Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Neuroimaging Initiative},
title = {Associations Between Hyperactive Neuropsychiatric Symptoms and Brain Morphology in Mild Cognitive Impairment and Alzheimer’s Disease},
journal = {Journal of Alzheimer's Disease},
year = {2024},
volume = {97},
number = {2},
pages = {841--853},
doi = {10.3233/jad-220857}
}
EUVIMED